STI multiplex test

STI multiplex test

Test for sexually transmitted infections

Rapid test results of co-infections.

The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient’s sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as other possible viral respiratory diseases. To prevent the continued rapid spread of COVID-19, it is necessary to identify infectious patients with and without symptoms. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment. The test delivers a reliable result based on WHO guidelines in less than 2.5 hours at the point of care, i.e. in close proximity to where the patient’s sample was collected. This means a time-consuming logistics chain, in which the samples have to be transported, is no longer necessary.

STI multiplex Test

Sample material:
Swab (genital), urine

Integration of sample preparation, DNA amplification, detection (µArray) and analysis on a single cartridge

Nucleic acid based testing for direct identification of 2 viral and 7 bacterial pathogens and 1 parasite

Detectable Pathogens

Detectable Pathogens

Chlamydia trachomatis
Herpes simplex virus II
Neisseria gonorrhoeae
Mycoplasma hominis
Trichomonas vaginalis
Mycoplasma genitalium
Treponema pallidum (syphilis)
Ureaplasma urealyticum
Herpes simplex virus I
Haemophilus ducreyi

Multiplex test for Sexually Transmitted Infections.

Discover more and download the STI Onepager